SAN DIEGO: Researchers found that Methotrexate (MTX), which is one thousandth of the cost of the current drug used to treat Myeloproliferative neoplasms (MPN), a group of blood disorders related to leukemia, can also provide relief.
The arthritis drug is commonly used at low doses to treat inflammatory diseases including rheumatoid arthritis, Crohn’s disease and psoriasis and has few side effects. It is also used in some cancers at much higher doses where the side effects are substantial and similar to other chemotherapy agents.